National Coverage Analysis (NCA)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndromes (MDS)

CAG-00415R

Expand All | Collapse All

Documents

Contacts

Lead Analysts
Kimberly Long
kimberly.long@cms.hhs.gov
410-786-5702
Lead Medical Officers
James Rollins M.D.

History of Considerations

History Title ID
Original Consideration Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome CAG-00415N View
First reconsideration Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndromes (MDS) CAG-00415R You are here